Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

1.48
+0.01000.68%
Post-market: 1.480.00000.00%19:50 EDT
Volume:1.77M
Turnover:2.60M
Market Cap:229.58M
PE:-1.18
High:1.50
Open:1.47
Low:1.43
Close:1.47
Loading ...

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
21 Nov 2024

Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

GlobeNewswire
·
21 Nov 2024

HUMA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

TIPRANKS
·
21 Nov 2024

Humacyte Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Nov 2024

Humacyte’s sdATEV device shows efficacy in artery bypass trial in primates

TIPRANKS
·
18 Nov 2024

Humacyte Prices $15 Million Registered Direct Offering

MT Newswires Live
·
14 Nov 2024

Humacyte prices 2.8M shares at $5.34 in registered direct offering

TIPRANKS
·
14 Nov 2024

BRIEF-Humacyte Announces Pricing Of $15.0 Million Registered Direct Offering

Reuters
·
14 Nov 2024

Humacyte Announces Pricing of $15.0 Million Registered Direct Offering

THOMSON REUTERS
·
14 Nov 2024

Humacyte Inc - to Sell 2,808,988 Shares and Warrants

THOMSON REUTERS
·
14 Nov 2024

Humacyte Announces Pricing of $15.0 Million Registered Direct Offering

GlobeNewswire
·
14 Nov 2024

Humacyte Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
12 Nov 2024

Benchmark Co. Sticks to Their Buy Rating for Humacyte (HUMA)

TIPRANKS
·
11 Nov 2024

Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital

TIPRANKS
·
10 Nov 2024

Humacyte rises 6% as regulators reviewing bioengineered human tissue asset

seekingalpha
·
09 Nov 2024

Humacyte Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Stock Track | Humacyte Stock Surges Despite Wider Q3 Losses, Investors Await Outlook

Stock Track
·
08 Nov 2024

Stock Track | Humacyte Shares Plunge as Q3 Earnings Miss Estimates

Stock Track
·
08 Nov 2024

Humacyte GAAP EPS of -$0.33 misses by $0.08

seekingalpha
·
08 Nov 2024